Recombinant Human Sodium/potassium-transporting ATPase subunit beta-3 (ATP1B3)

Definition and Basic Characteristics

Sodium/potassium-transporting ATPase subunit beta-3 (ATP1B3) represents one of the beta subunits of the Na+/K+-ATPase complex, a fundamental enzyme responsible for maintaining electrochemical gradients across cellular membranes . The human ATP1B3 protein consists of 279 amino acids and functions as a regulatory component that associates with catalytic alpha subunits to form the complete and functional Na+/K+-ATPase enzyme complex . As a recombinant protein, ATP1B3 is produced through various expression systems and is available commercially for research applications with different tags and specifications .

Molecular Structure and Protein Characteristics

ATP1B3 contains multiple functional domains that contribute to its specific interactions with other proteins and its role in the Na+/K+-ATPase complex. The protein undergoes post-translational modifications, particularly glycosylation, which appears to be critical for its proper localization and function . Commercial recombinant versions often include specific segments of the full-length protein, such as amino acids 61-273, which contain key functional domains while excluding signal peptides or transmembrane regions that might complicate expression and purification .

Expression Systems and Production Methods

Recombinant ATP1B3 is produced using several expression systems, each offering distinct advantages for research applications. The most common expression platforms include:

1. Prokaryotic systems (Escherichia coli): Provide high yield but lack post-translational modifications like glycosylation

2. Eukaryotic systems (HEK-293 cells): Offer proper protein folding and post-translational modifications similar to native human proteins

3. Cell-free systems (Wheat germ): Allow expression of proteins that might be toxic to host cells

Purification and Quality Control

Recombinant ATP1B3 proteins undergo rigorous purification processes, typically utilizing affinity chromatography based on fusion tags such as polyhistidine (His) or glutathione S-transferase (GST) . Quality control measures include SDS-PAGE analysis for purity assessment, with commercial products often exceeding 90-97% purity . These high-purity preparations are essential for reliable experimental results and applications in immunological studies, protein-protein interaction analyses, and functional assays.

Role in Enzyme Complex Assembly

ATP1B3 serves as a critical regulatory component of the Na+/K+-ATPase complex, mediating the proper assembly and trafficking of the complete enzyme . Research has demonstrated that ATP1B3 specifically interacts with the alpha-1 subunit of Na+/K+-ATPase, which constitutes the major catalytic component of the functional complex . This interaction is essential for stabilizing the alpha subunit and facilitating its transport from the endoplasmic reticulum to the plasma membrane.

Impact on Enzyme Activity and Regulation

The beta-3 subunit influences both the catalytic activity and regulatory properties of the Na+/K+-ATPase complex. Studies investigating the activity of Na+/K+-ATPase in relation to ATP1B3 have shown that alterations in ATP1B3 expression or processing directly affect the enzyme's ability to transport ions across cellular membranes . These findings highlight the crucial role of ATP1B3 in maintaining cellular ion homeostasis and membrane potential.

Tissue-Specific Expression and Function

While the search results do not provide comprehensive information about ATP1B3's tissue-specific expression patterns, the protein has been identified in brain microvascular endothelial cells, suggesting an important role in the central nervous system and blood-brain barrier function . The specific distribution of ATP1B3 across different tissues and cell types likely contributes to specialized functions of the Na+/K+-ATPase complex in various physiological contexts.

Interaction with Enterovirus 71

Research has identified a novel interaction between ATP1B3 and the 3A protein of Enterovirus 71 (EV71), a pathogen associated with hand, foot, and mouth disease and neurological complications . This interaction was initially discovered through yeast two-hybrid assays and subsequently confirmed through multiple experimental approaches including immunofluorescent co-localization analysis and co-immunoprecipitation studies . Interestingly, confocal microscopic analysis revealed that the 3A fusion protein co-localizes with ATP1B3 on the membrane of infected cells, suggesting a functional relationship during viral infection .

Antiviral Effects and Mechanisms

ATP1B3 exhibits significant antiviral properties against EV71 infection. Studies have demonstrated that:

1. EV71 infection increases ATP1B3 expression in infected cells at both mRNA and protein levels

2. ATP1B3 expression levels positively correlate with infection time and viral dose

3. Knockdown of ATP1B3 using siRNA significantly enhances EV71 replication

4. Overexpression of ATP1B3 substantially suppresses viral replication

These findings establish ATP1B3 as a virus-induced host factor that paradoxically inhibits viral proliferation, suggesting an important role in cellular antiviral defense mechanisms .

Regulation of Type I Interferon Response

The mechanism underlying ATP1B3's antiviral activity appears to involve the stimulation of type I interferon (IFN) production . Experimental data shows that:

1. ATP1B3 knockdown significantly decreases intracellular levels of IFN-α/β mRNA

2. ATP1B3 overexpression substantially increases IFN-α/β mRNA levels

3. Neutralization of type I interferons using specific antibodies reverses the ATP1B3-mediated inhibition of viral growth

Table 2: ATP1B3 Effects on Viral Infection and Immune Response

These results establish ATP1B3 as a potential therapeutic target for enhancing antiviral immunity, particularly against EV71 infection .

Interaction with CASPR1

Recent research has identified a significant interaction between ATP1B3 and Contactin-associated protein 1 (CASPR1 or CNTNAP1) in brain microvascular endothelial cells (BMECs), which are the primary cellular component of the blood-brain barrier . This interaction was discovered through yeast two-hybrid screening using CASPR1 as bait, followed by validation using multiple complementary approaches including GST-pulldown, immunofluorescence, and co-immunoprecipitation assays .

Notably, only the core proteins of ATP1B3, not its glycosylated forms, interact with CASPR1, with this interaction primarily occurring in the endoplasmic reticulum of BMECs . This specificity suggests a selective mechanism involving early-stage processing of ATP1B3 before its full maturation and trafficking to the plasma membrane.

Regulation of Na+/K+-ATPase Maturation and Trafficking

The CASPR1-ATP1B3 interaction plays a critical role in regulating Na+/K+-ATPase maturation and membrane localization . Experimental evidence demonstrates that:

1. CASPR1 knockdown reduces ATP1B3 glycosylation, a critical post-translational modification

2. CASPR1 depletion prevents ATP1B3 localization to the plasma membrane

3. These effects can be reversed by expression of full-length CASPR1

4. CASPR1 knockdown reduces plasma membrane distribution of the alpha-1 subunit of Na+/K+-ATPase

These findings establish CASPR1 as an important regulator of ATP1B3 processing and, consequently, Na+/K+-ATPase assembly and function .

Impact on Glutamate Transport and CNS Homeostasis

The functional significance of the CASPR1-ATP1B3 interaction extends to glutamate transport across the blood-brain barrier, a process crucial for central nervous system homeostasis . Research has shown that:

1. CASPR1 silencing using shRNA reduces glutamate efflux through BMECs

2. Na+/K+-ATPase activity is diminished in CASPR1-silenced BMECs

3. CASPR1 binds with ATP1B3 but not with the alpha-1 subunit, suggesting a specific role in facilitating Na+/K+-ATPase assembly

These results highlight the importance of CASPR1-mediated regulation of ATP1B3 and Na+/K+-ATPase function in maintaining the specialized properties of the blood-brain barrier and regulating neurotransmitter levels in the central nervous system .

Research Applications

Recombinant ATP1B3 serves various research purposes, including:

1. Protein-protein interaction studies to identify novel binding partners and cellular pathways

2. Functional assays to assess Na+/K+-ATPase activity under different experimental conditions

3. Immunological studies as antigens for antibody production and validation

4. Structural analyses to elucidate the three-dimensional organization of Na+/K+-ATPase complexes

Potential Therapeutic Applications

The emerging understanding of ATP1B3's roles in viral immunity and blood-brain barrier function suggests several promising therapeutic applications:

1. Antiviral strategies: Enhancing ATP1B3 expression or activity could potentially boost innate immunity against EV71 and possibly other viral infections

2. Blood-brain barrier modulation: Targeting the CASPR1-ATP1B3 interaction might allow for controlled regulation of blood-brain barrier permeability in conditions requiring enhanced drug delivery to the central nervous system

3. Neuroprotective approaches: Maintaining proper ATP1B3 function could help preserve blood-brain barrier integrity and glutamate homeostasis in neurological disorders

Diagnostic Potential

Given its specific interactions and regulatory functions, ATP1B3 might serve as a biomarker for certain pathological conditions, particularly those involving:

1. Viral infections where ATP1B3 expression changes correlate with disease progression

2. Blood-brain barrier dysfunction in neurological disorders

3. Ion transport abnormalities in various tissues

Expanded Protein Interaction Networks

While interactions with EV71 3A protein and CASPR1 have been identified, ATP1B3 likely participates in additional protein-protein interactions that contribute to its diverse biological functions. Comprehensive interactome studies using advanced proteomics approaches would help uncover these networks and potentially identify new therapeutic targets.

Therapeutic Development

The antiviral properties of ATP1B3 and its role in blood-brain barrier function warrant further investigation for therapeutic development. Potential approaches include:

1. Small molecule modulators of ATP1B3 function or expression

2. Peptide-based therapeutics targeting specific protein-protein interactions

3. Gene therapy approaches to regulate ATP1B3 expression in specific tissues